tiprankstipranks
Trending News
More News >
Adial Pharmaceuticals Inc (ADIL)
NASDAQ:ADIL
US Market

Adial Pharmaceuticals (ADIL) Financial Statements

Compare
603 Followers

Adial Pharmaceuticals Financial Overview

Adial Pharmaceuticals's market cap is currently $6.47M. The company's EPS TTM is $-0.08; its P/E ratio is -0.24; Adial Pharmaceuticals is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is $-0.08. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -564.00$ 0.00$ 0.00$ -564.00
Operating Income$ -8.28M$ -6.89M$ -10.86M$ -19.29M$ -10.93M
EBITDA$ -8.28M$ -7.00M$ -10.86M$ -17.69M$ -10.93M
Net Income$ -13.20M$ -7.00M$ -12.73M$ -19.42M$ -10.86M
Balance Sheet
Cash & Short-Term Investments$ 3.75M$ 2.83M$ 4.00M$ 6.06M$ 4.40M
Total Assets$ 5.04M$ 4.74M$ 5.73M$ 7.63M$ 5.49M
Total Debt$ 0.00$ 0.00$ 207.38K$ 256.96K$ 0.00
Net Debt$ -3.75M$ -2.83M$ -3.79M$ -5.81M$ -4.40M
Total Liabilities$ 975.86K$ 653.51K$ 2.46M$ 4.13M$ 1.51M
Stockholders' Equity$ 4.07M$ 4.08M$ 3.28M$ 3.51M$ 3.99M
Cash Flow
Free Cash Flow$ -6.92M$ 0.00$ -11.19M$ -12.01M$ -7.63M
Operating Cash Flow$ -6.92M$ -6.81M$ -11.19M$ -11.95M$ -7.63M
Investing Cash Flow$ 0.00$ 1.50M$ 0.00$ -34.02K$ -350.00K
Financing Cash Flow$ 7.85M$ 4.13M$ 9.13M$ 13.64M$ 5.61M
Currency in USD

Adial Pharmaceuticals Earnings and Revenue History

Adial Pharmaceuticals Debt to Assets

Adial Pharmaceuticals Cash Flow

Adial Pharmaceuticals Forecast EPS vs Actual EPS